BioWorld MedTech

Jan. 27, 2012

Patients have better quality of life when treated with IMRT

A new study shows that patients treated with intensity modulated radiation therapy (IMRT), have an increasingly better quality of life post treatment when compared to patients receiving other forms of radiation therapy. Read More

Report from Europe: Boston Scientific welcomes new NICE guidance on BT for asthma

'Quest' for companion diagnostics: Personalized approach renews Tysabri's potential in MS space

Washington roundup: CDRH will commence with triage of applications in April

Financings roundup: Sequenom raises about $62M in gross proceeds from stock sale

Deals roundup: Bruker acquires assets of Hecus's MicrocaliX line

Patent roundup: EF Precision Group receives patent for new orthopedic mallet

Agreements/contracts: M*Modal in partnership with Merge for speech technology

Court report: Court denies motion to stop NuVasive sales

HIT roundup: Integware reports teaming up with Siemens PLM Software

Med-Tech Notes: Catholic Healthcare West now Dignity Health

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for July 9, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...